Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny D Shen

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Pharmacological Research|January 24, 2017
P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphineMichael Z Liao, Chunying Gao, Laura M Shireman, et al.
Therapeutic Drug Monitoring|September 26, 2012
Pharmacokinetics of tacrolimus during pregnancySongmao Zheng, Thomas R Easterling, Jason G Umans, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 9, 2016
Effect of Coenzyme Q<sub>10</sub> on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ<sub>10</sub> Biomarker TrialMatthew B Rivara, Catherine K Yeung, Cassianne Robinson-Cohen, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
Plos One|December 7, 2017
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteersSophia E Airhart, Laura M Shireman, Linda J Risler, et al.
Pharmaceutical Research|September 13, 2023
Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney DiseaseShih-Yu Chang, Weize Huang, Alenka Chapron, et al.
JACC. Basic to Translational Science|January 16, 2023
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection FractionDennis D Wang, Sophia E Airhart, Bo Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2013
Specialty supplement use and biologic measures of oxidative stress and DNA damageElizabeth D Kantor, Cornelia M Ulrich, Robert W Owen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended ApproachEmily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Pharmacotherapy|March 12, 2015
Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substratesLingtak-Neander Chan, Yvonne S Lin, Jessica C Tay-Sontheimer, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Pharmacological Research|January 24, 2017
P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphineMichael Z Liao, Chunying Gao, Laura M Shireman, et al.
Therapeutic Drug Monitoring|September 26, 2012
Pharmacokinetics of tacrolimus during pregnancySongmao Zheng, Thomas R Easterling, Jason G Umans, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 9, 2016
Effect of Coenzyme Q<sub>10</sub> on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ<sub>10</sub> Biomarker TrialMatthew B Rivara, Catherine K Yeung, Cassianne Robinson-Cohen, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
Plos One|December 7, 2017
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteersSophia E Airhart, Laura M Shireman, Linda J Risler, et al.
Pharmaceutical Research|September 13, 2023
Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney DiseaseShih-Yu Chang, Weize Huang, Alenka Chapron, et al.
JACC. Basic to Translational Science|January 16, 2023
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection FractionDennis D Wang, Sophia E Airhart, Bo Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2013
Specialty supplement use and biologic measures of oxidative stress and DNA damageElizabeth D Kantor, Cornelia M Ulrich, Robert W Owen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended ApproachEmily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Pharmacotherapy|March 12, 2015
Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substratesLingtak-Neander Chan, Yvonne S Lin, Jessica C Tay-Sontheimer, et al.
Pageof 10